Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
ITāS BEEN A BUSY YEAR AND I HOPE NO ONE THINKS weāve been remiss by not mentioning a milestone anniversary until now. On the other hand, I personally canāt recall reading about this anniversary elsewhere in the lab industry press during 2005. So maybe I am among the few to call attention to the fact […]
PCR Celebrates Its Twentieth Anniversary in 2005 Read More Ā»
CEO SUMMARY: Too often local pathology groups fail to react to intensified sales competition for the biopsy referrals of clinicians in their community. In Torrance, California, the 30 pathologists of Pathology, Inc. decided it was time to invest capital and resources into developing their own flavor of āvalue-addedā pathology services. These custom-tailored pathology reports are
Innovative AP Reports Created by Path Group Read More Ā»
CEO SUMMARY: In many ways, this acquisition would appear to be the āsame old storyā of lab consolidation that has marked the lab industry for almost 20 years. Yet, beneath the surface is an unexpected dimension: a motive to use the resources of both companies to better position Quest Diagnostics Incorporated to compete in the
Quest Pays $934 Million In Acquisition of LabOne Read More Ā»
CEO SUMMARY: In the 15 years it has operated a molecular diagnostics testing program, Beaumont Reference Laboratory (BRL) has learned important lessons on how to evaluate which specific molecular assays are ready for clinical introduction. It has also learned effective ways to anticipate the clinical and financial success of such assays. Part II of this
Picking Winners and Losers For the Molecular Test Menu Read More Ā»
CEO SUMMARY: Proteomics-based technology is developing rapidly. The strategic collaboration announced last month between Ciphergen Biosystems and Quest Diagnostics Incorporated is potentially worth $25 million. It is an expensive bet that next-generation proteomics tests soon to enter the clinical marketplace will provide high clinical utility and give physicians new diagnostic tools. NEW PROTEOMIC-BASED TECHNOLOGIES ARE
Proteomic Tests Poised For Clinical Market Read More Ā»
In California, some physicians continue to seek illegal kickbacks from clinical laboratories. The problem is widespread enough that the FBI has conducted several āsting operations.ā In a jury trial related to the long-running āDurascamā healthcare fraud investigation, a married pair of doctors, Adelina Vorperian, M.D. and Kevork Vorperian, M.D., were convicted on charges of accepting
“August 22, 2005 Intelligence: Late Breaking Lab News” Read More Ā»
The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com
Ā© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group